Aia America, Inc. v. Eli Lilly & Company

       NOTE: This disposition is nonprecedential.


  United States Court of Appeals
      for the Federal Circuit
                ______________________

      AIA AMERICA, INC., FKA ALZHEIMER'S
          INSTITUTE OF AMERICA, INC.,
                Plaintiff-Appellant

   MICHAEL J. MULLAN, RONALD E. SEXTON,
           Counterclaim Defendants

                           v.

           ELI LILLY & COMPANY, ELAN
            PHARMACEUTICALS, INC.,
                 Defendants-Appellees
                ______________________

                      2016-2094
                ______________________

   Appeal from the United States District Court for the
Northern District of California in No. 3:10-cv-00482-EDL,
Magistrate Judge Elizabeth D. Laporte.
                 ______________________

                     JUDGMENT
                ______________________

   PETER BUCKLEY, Fox Rothschild, LLP, Philadelphia,
PA, argued for plaintiff-appellant.

   DEBORAH E. FISHMAN, Arnold & Porter Kaye Scholer
LLP, Palo Alto, CA, argued for all defendants-appellees.
Defendant-appellee Elan Pharmaceuticals,       Inc.   also
represented by KATIE JEANNINE LEWIS SCOTT.

    LAWRENCE SCOTT BURWELL, Finnegan, Henderson,
Farabow, Garrett & Dunner, LLP, Reston, VA, for de-
fendant-appellee Eli Lilly & Company. Also represented
by CHARLES E. LIPSEY; LAURA POLLARD MASUROVSKY,
Washington, DC; MANISHA A. DESAI, Eli Lilly and Com-
pany, Indianapolis, IN.
                 ______________________

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:



   PER CURIAM (NEWMAN, LOURIE, and HUGHES, Circuit
Judges).
           AFFIRMED. See Fed. Cir. R. 36.

                      ENTERED BY ORDER OF THE COURT


  August 10, 2017                /s/ Peter R. Marksteiner
      Date                       Peter R. Marksteiner
                                 Clerk of Court